Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
American Journal of Human Genetics|August 27, 1998
Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of boneM J Nellissery, S S Padalecki, Z Brkanac, et al.The Journal of Clinical Investigation|December 1, 1991
Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferationT Hongo, J Kupfer, H Enomoto, et al.The American Journal of Medicine|March 1, 1983
Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalaciaA B Hodsman, E G Wong, D J Sherrard, et al.The Journal of Clinical Investigation|June 23, 2000
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of boneC Menaa, S V Reddy, N Kurihara, et al.Life Sciences|May 3, 1982
Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in manM E Berger, M S Golub, J R Sowers, et al.Annals of Internal Medicine|May 1, 1981
Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidismA B Hodsman, D J Sherrard, E G Wong, et al.Human Molecular Genetics|December 14, 2001
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel geneE Cleiren, O Bénichou, E Van Hul, et al.The American Journal of Medicine|August 1, 1995
Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodelingC H Chesnut, M R McClung, K E Ensrud, et al.The American Journal of Medicine|November 14, 1997
Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal womenJ L Stock, N H Bell, C H Chesnut, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 17, 1998
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter studyE S Siris, A A Chines, R D Altman, et al.Pageof 11